The CNS disorder-focused drug developer has filed to raise up to $125m having raised $226m in funding from backers including Eli Lilly and Access Industries.
The online streaming platform is seeking a reported $50m from existing investors that include JTBC, Yoshimoto Kogyo, MNC, Liberty Global, Sky, PLDT, Zain Group and Hearst.
The GV-backed primary care membership service floated at the bottom of its range but garnered a valution of more than $1.7bn.
Wuxi AppTec and Alphabet are in line to exit the molecule-discovery software provider, which has set the range for its initial public offering.
Sanofi is in line for an exit as Revolution Medicines files for a $100m initial public offering on the Nasdaq Global Market.
Bertelsmann achieved an exit as the cloud services provider raised $284m in an initial public offering that reportedly valued it at about $2bn.